GENETIC-FACTORS IN TOXICOLOGY - IMPLICATIONS FOR TOXICOLOGICAL SCREENING

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164

[2] Altman AR, 1985, STATISTICIAN, V34, P125

[3] [Anonymous], GENETICS MOUSE

[4] ARCOS JC, 1968, CHEM INDUCTION CANCE

[5] DRUG DISCONTINUATIONS IN THE UNITED-KINGDOM AND THE UNITED-STATES, 1964 TO 1983 - ISSUES OF SAFETY [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) : 559 - 567

[6] BLACK D, 1979, IATROGENIC DISEASE

[7] GLUCOCORTICOID-INDUCED CLEFT-PALATE GENES IN CHROMOSOME-17 - GENETIC-LINKAGE AND MAPPING ANALYSES [J]. IMMUNOGENETICS, 1984, 20 (02) : 169 - 183

[8] BLOOD-PRESSURE IN RATS - A COMPARISON OF A MULTIFACTORIAL EXPERIMENTAL-DESIGN TO MEASUREMENTS IN AN OUTBRED STOCK [J]. LABORATORY ANIMALS, 1984, 18 (02) : 110 - 114

[9] Campbell J S, 1981, Methods Achiev Exp Pathol, V10, P221

[10] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J]. DRUGS, 1985, 29 (04) : 342 - 375

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164

[2] Altman AR, 1985, STATISTICIAN, V34, P125

[3] [Anonymous], GENETICS MOUSE

[4] ARCOS JC, 1968, CHEM INDUCTION CANCE

[5] DRUG DISCONTINUATIONS IN THE UNITED-KINGDOM AND THE UNITED-STATES, 1964 TO 1983 - ISSUES OF SAFETY [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) : 559 - 567

[6] BLACK D, 1979, IATROGENIC DISEASE

[7] GLUCOCORTICOID-INDUCED CLEFT-PALATE GENES IN CHROMOSOME-17 - GENETIC-LINKAGE AND MAPPING ANALYSES [J]. IMMUNOGENETICS, 1984, 20 (02) : 169 - 183

[8] BLOOD-PRESSURE IN RATS - A COMPARISON OF A MULTIFACTORIAL EXPERIMENTAL-DESIGN TO MEASUREMENTS IN AN OUTBRED STOCK [J]. LABORATORY ANIMALS, 1984, 18 (02) : 110 - 114

[9] Campbell J S, 1981, Methods Achiev Exp Pathol, V10, P221

[10] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J]. DRUGS, 1985, 29 (04) : 342 - 375